Document Detail


Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.
MedLine Citation:
PMID:  20830466     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIMS/HYPOTHESIS: The aim of this study was to determine whether the mean size of fat cells in either visceral or subcutaneous adipose tissue has an impact on the metabolic and inflammatory profiles in morbid obesity.
METHODS: In 80 morbidly obese women, mean visceral (omental) and subcutaneous fat cell sizes were related to in vivo markers of inflammation, glucose metabolism and lipid metabolism.
RESULTS: Visceral, but not subcutaneous, adipocyte size was significantly associated with plasma apolipoprotein B, total cholesterol, LDL-cholesterol and triacylglycerols (p ranging from 0.002 to 0.015, partial r ranging from 0.3 to 0.4). Subcutaneous, but not visceral, adipocyte size was significantly associated with plasma insulin and glucose, insulin-induced glucose disposal and insulin sensitivity (p ranging from 0.002 to 0.005, partial r ranging from -0.34 to 0.35). The associations were independent of age, BMI, body fat mass or body fat distribution. Adipose tissue hyperplasia (i.e. many small adipocytes) in both regions was significantly associated with better glucose, insulin and lipid profiles compared with adipose hypertrophy (i.e. few large adipocytes) in any or both regions (p ranging from <0.0001 to 0.04). Circulating inflammatory markers were not associated with fat cell size or corresponding gene expression in the fat cell regions examined.
CONCLUSIONS/INTERPRETATION: In morbidly obese women region-specific variations in mean adipocyte size are associated with metabolic complications but not systemic or adipose inflammation. Large fat cells in the visceral region are linked to dyslipidaemia, whereas large subcutaneous adipocytes are important for glucose and insulin abnormalities. Hyperplasia (many small adipocytes) in both adipose regions may be protective against lipid as well as glucose/insulin abnormalities in obesity.
Authors:
J Hoffstedt; E Arner; H Wahrenberg; D P Andersson; V Qvisth; P Löfgren; M Rydén; A Thörne; M Wirén; M Palmér; A Thorell; E Toft; P Arner
Related Documents :
20847546 - Normal-weight 14-year-old girl with acanthosis nigricans and markedly increased hepatic...
15111536 - Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes.
10857936 - Visceral adiposity and risk of type 2 diabetes: a prospective study among japanese amer...
3578256 - Environmental and behavioral determinants of fasting plasma glucose in women. a matched...
6721016 - A randomized study of the impact of home health aides on diabetic control and utilizati...
21133896 - Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in no...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-10
Journal Detail:
Title:  Diabetologia     Volume:  53     ISSN:  1432-0428     ISO Abbreviation:  Diabetologia     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  2496-503     Citation Subset:  IM    
Affiliation:
Department of Medicine, Karolinska Institute at Karolinska Hospital, Huddinge, CME, SE-141 86 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chromosomal loci associated with endosperm hardness in a malting barley cross.
Next Document:  [Slipped capital femoral epiphysis].